Table 1 The detailed clinical features of CRC patients in TCGA database
From: KCNJ14 knockdown significantly inhibited the proliferation and migration of colorectal cells
Covariates | Type | Total | Percentages (%) |
|---|---|---|---|
Age | <=65 | 146 | 43.07 |
>65 | 193 | 56.93 | |
Gender | Female | 159 | 46.9 |
Male | 180 | 53.1 | |
Lymphatic invasion | No | 203 | 59.88 |
Yes | 136 | 40.12 | |
Pathologic_M | M0 | 269 | 79.35 |
M1 | 44 | 12.98 | |
M2 | 26 | 7.67 | |
Pathologic_N | N0 | 197 | 58.11 |
N1 | 84 | 24.78 | |
N2 | 58 | 17.11 | |
Pathologic_T | T1 | 9 | 2.65 |
T2 | 60 | 17.7 | |
T3 | 232 | 68.44 | |
T4 | 38 | 11.21 | |
Tumor_stage | Stage I | 59 | 17.4 |
Stage II | 135 | 39.82 | |
Stage III | 100 | 29.5 | |
Stage IV | 45 | 13.28 | |
KCNJ14 expression | High | 170 | 50.15 |
Low | 169 | 49.85 |